Welcome to LookChem.com Sign In|Join Free

CAS

  • or

16082-65-8

Post Buying Request

16082-65-8 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

16082-65-8 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 16082-65-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,6,0,8 and 2 respectively; the second part has 2 digits, 6 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 16082-65:
(7*1)+(6*6)+(5*0)+(4*8)+(3*2)+(2*6)+(1*5)=98
98 % 10 = 8
So 16082-65-8 is a valid CAS Registry Number.

16082-65-8Relevant articles and documents

Cobalt catalyzed electrochemical [4 + 2] annulation for the synthesis of sultams

Cao, Yangmin,Yuan, Yong,Lin, Yueping,Jiang, Xiaomei,Weng, Yaqing,Wang, Tangwei,Bu, Faxiang,Zeng, Li,Lei, Aiwen

, p. 1548 - 1552 (2020/03/26)

Cobalt catalyzed electrochemical [4 + 2] annulation of sulfonamides with alkynes is demonstrated in this work, which provided a practical and environmentally friendly way to synthesize structurally diverse sultams. Notably, by employing anodic oxidation in an undivided cell to recycle the cobalt catalyst, this electrochemical method avoided the utilization of stoichiometric amount of metallic oxidant, delivering H2 as the sole by-product. Moreover, this cobalt catalyzed electrochemical protocol proved to be practical and scalable. When the model reaction was scaled up to 5.0 mmol, 86% yield of product could still be obtained.

Rhodium(i)-catalyzed mono-selective C-H alkylation of benzenesulfonamides with terminal alkenes

Rej, Supriya,Chatani, Naoto

supporting information, p. 10503 - 10506 (2019/09/12)

The Rh(i)-catalyzed ortho-alkylation of benzenesulfonamides with alkenes with the aid of an 8-aminoquinoline directing group is reported. The reaction is applicable to a variety of benzenesulfonamide derivatives and various alkenes. Curiously, unactivated

Small molecule SUMOylation activators are novel neuroprotective agents

Krajnak, Katherine,Dahl, Russell

, p. 405 - 409 (2017/12/26)

Neuronal loss characterizes many of the most intractable nervous system diseases that deprive our ageing population of their quality of life. Neuroprotective pharmacological modalities are urgently needed to address this burgeoning population. Small ubiqu

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 16082-65-8